| Nazish Ahmad, MD | |
|
2 Capital Way Ste 290, Pennington, NJ 08534-2521 | |
| (609) 303-4300 | |
| (609) 303-4301 |
| Full Name | Nazish Ahmad |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 16 Years |
| Location | 2 Capital Way Ste 290, Pennington, New Jersey |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1295098903 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207R00000X | Internal Medicine | 25MA09777800 (New Jersey) | Secondary |
| 207RE0101X | Internal Medicine - Endocrinology, Diabetes & Metabolism | 25MA09777800 (New Jersey) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Capital Health Medical Center - Hopewell | Pennington, NJ | Hospital |
| Capital Health Regional Medical Center | Trenton, NJ | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Capital Health Medical Group | 7618264532 | 364 |
News Archive
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
A new epilepsy gene, LGI2, has been found in the Lagotto Romagnolo dogs, known from their gift for truffle hunting. The gene discovery made by Professor Hannes Lohi and his research group at the University of Helsinki and the Folkhälsan Rsearch Center offers a new candidate gene for human benign childhood epilepsies characterized by seizure remission.
The American Medical Group Association (AMGA) today announced 19 leading medical groups and organized systems of care that will be participating in its ACO Development Collaborative, scheduled to have its first meeting in conjunction with the AMGA National Summit on Accountable Care Organizations (ACOs). These organizations represent more than 10,500 providers serving approximately 5 million patients in the United States.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 1 days ago
| Entity Name | Capital Health Medical Group |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1437516887 PECOS PAC ID: 7618264532 Enrollment ID: O20160921000449 |
News Archive
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
A new epilepsy gene, LGI2, has been found in the Lagotto Romagnolo dogs, known from their gift for truffle hunting. The gene discovery made by Professor Hannes Lohi and his research group at the University of Helsinki and the Folkhälsan Rsearch Center offers a new candidate gene for human benign childhood epilepsies characterized by seizure remission.
The American Medical Group Association (AMGA) today announced 19 leading medical groups and organized systems of care that will be participating in its ACO Development Collaborative, scheduled to have its first meeting in conjunction with the AMGA National Summit on Accountable Care Organizations (ACOs). These organizations represent more than 10,500 providers serving approximately 5 million patients in the United States.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 1 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Nazish Ahmad, MD 2 Capital Way Ste 290, Pennington, NJ 08534-2521 Ph: (609) 303-4300 | Nazish Ahmad, MD 2 Capital Way Ste 290, Pennington, NJ 08534-2521 Ph: (609) 303-4300 |
News Archive
Aastrom Biosciences, Inc., a leading developer of expanded autologous cellular therapies for the treatment of severe cardiovascular diseases, today announced that the U.S. Food & Drug Administration (FDA) has granted fast track designation for the company's critical limb ischemia (CLI) cell therapy development program. Aastrom plans to initiate Phase 3 clinical testing of its treatment for CLI in early 2011.
A new epilepsy gene, LGI2, has been found in the Lagotto Romagnolo dogs, known from their gift for truffle hunting. The gene discovery made by Professor Hannes Lohi and his research group at the University of Helsinki and the Folkhälsan Rsearch Center offers a new candidate gene for human benign childhood epilepsies characterized by seizure remission.
The American Medical Group Association (AMGA) today announced 19 leading medical groups and organized systems of care that will be participating in its ACO Development Collaborative, scheduled to have its first meeting in conjunction with the AMGA National Summit on Accountable Care Organizations (ACOs). These organizations represent more than 10,500 providers serving approximately 5 million patients in the United States.
CAQH announced today that BlueCross BlueShield of Tennessee has achieved certification for its implementation of the CAQH Committee on Operating Rules for Information Exchange Phase II rules. The certification will benefit more than 3 million insured members of the Tennessee health plan.
› Verified 1 days ago
Neil Saxena, MD Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 385, Pennington, NJ 08534 Phone: 609-303-4838 Fax: 609-303-4835 | |
Madhuri Adabala, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 | |
Mowyad Omer Elamin Khalid, M.D Endocrinology, Diabetes & Metabolism Medicare: Medicare Enrolled Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 Fax: 609-303-4361 | |
Rishi Patel, Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 2 Capital Way Ste 550, Pennington, NJ 08534 Phone: 609-303-4360 | |
Dr. Brian Adam Meltzer, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 6 E Acres Dr, Pennington, NJ 08534 Phone: 609-737-1903 Fax: 732-247-5309 | |
Marie Antoinette Marquez, M.D. Endocrinology, Diabetes & Metabolism Medicare: Not Enrolled in Medicare Practice Location: 1300 Merrill Lynch Dr, Pennington, NJ 08534 Phone: 609-274-6000 | |
Anita Maraj, M.D. Endocrinology, Diabetes & Metabolism Medicare: Accepting Medicare Assignments Practice Location: 1 Capital Way, Pennington, NJ 08534 Phone: 609-303-4000 |